T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
NXP Semiconductors
NXPI
|
$1.48B |
| 2 |
Philip Morris
PM
|
$1.39B |
| 3 |
Amazon
AMZN
|
$1.26B |
| 4 |
Stryker
SYK
|
$1.22B |
| 5 |
AET
Aetna Inc
AET
|
$1.14B |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$1.12B |
| 2 |
Willis Towers Watson
WTW
|
$1.1B |
| 3 |
Walt Disney
DIS
|
$890M |
| 4 |
Akamai
AKAM
|
$769M |
| 5 |
Chipotle Mexican Grill
CMG
|
$641M |
Sector Composition
| 1 | Healthcare | 20.69% |
| 2 | Consumer Discretionary | 15.01% |
| 3 | Financials | 13.64% |
| 4 | Technology | 12.55% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AET
26
DELISTED
Aetna Inc
AET
| $3.3B | 0.7% | 29,330,165 +10,120,164 | +53% | +$1.14B |
|
27
JPMorgan Chase
JPM
$829B
| $3.29B | 0.7% | 55,488,304 -1,969,345 | -3% | -$117M |
|
28
American Tower
AMT
$95.5B
| $3.23B | 0.69% | 31,522,276 -2,759,584 | -8% | -$282M |
|
29
Salesforce
CRM
$245B
| $3.04B | 0.65% | 41,233,810 +10,547,719 | +34% | +$779M |
|
30
Fiserv
FI
$75.1B
| $2.84B | 0.61% | 27,728,360 -3,524,867 | -11% | -$362M |
|
31
AutoZone
AZO
$70.2B
| $2.72B | 0.58% | 3,409,070 -172,850 | -5% | -$138M |
|
32
Exxon Mobil
XOM
$487B
| $2.62B | 0.56% | 31,318,344 -3,445,582 | -10% | -$288M |
|
33
Intercontinental Exchange
ICE
$101B
| $2.51B | 0.54% | 10,659,049 -2,640 | -0% | -$621K |
|
|
34
Gilead Sciences
GILD
$140B
| $2.49B | 0.53% | 27,083,581 -12,143,707 | -31% | -$1.12B |
|
35
Roper Technologies
ROP
$56.6B
| $2.46B | 0.53% | 13,483,591 -1,183,066 | -8% | -$216M |
|
36
Becton Dickinson
BDX
$55.3B
| $2.39B | 0.51% | 15,734,208 -1,195,566 | -7% | -$182M |
|
37
PG&E
PCG
$33.6B
| $2.37B | 0.51% | 39,654,356 -5,049,787 | -11% | -$302M |
|
38
Bank of New York Mellon
BK
$74.5B
| $2.27B | 0.49% | 61,698,542 +4,785,399 | +8% | +$176M |
|
|
39
NXP Semiconductors
NXPI
$59.2B
| $2.24B | 0.48% | 27,581,859 +18,233,230 | +195% | +$1.48B |
|
|
CELG
40
DELISTED
Celgene Corp
CELG
| $2.18B | 0.47% | 21,798,524 -4,477,414 | -17% | -$448M |
|
|
WBA
41
DELISTED
Walgreens Boots Alliance
WBA
| $2.13B | 0.46% | 25,336,346 +3,979,670 | +19% | +$335M |
|
42
Biogen
BIIB
$19.4B
| $2.11B | 0.45% | 8,119,909 +1,759,477 | +28% | +$458M |
|
43
Humana
HUM
$36.5B
| $2.06B | 0.44% | 11,246,667 +1,633,372 | +17% | +$299M |
|
44
Comcast
CMCSA
$125B
| $2B | 0.43% | 32,825,090 +2,815,071 | +9% | +$172M |
|
45
Vertex Pharmaceuticals
VRTX
$100B
| $1.99B | 0.42% | 25,008,493 +6,185,022 | +33% | +$492M |
|
46
Johnson & Johnson
JNJ
$427B
| $1.96B | 0.42% | 18,157,199 -1,123,860 | -6% | -$122M |
|
47
McKesson
MCK
$85.4B
| $1.94B | 0.41% | 12,318,088 -2,927,662 | -19% | -$460M |
|
48
Cigna
CI
$80.3B
| $1.93B | 0.41% | 14,048,137 +1,264,724 | +10% | +$174M |
|
|
AMTD
49
DELISTED
TD Ameritrade Holding Corp
AMTD
| $1.89B | 0.4% | 60,043,954 +11,565,680 | +24% | +$365M |
|
50
Citigroup
C
$178B
| $1.86B | 0.4% | 44,564,735 +848,822 | +2% | +$35.4M |
|